Concepedia

Marta Castroviejo‐Bermejo

MC

Statistics

Publications

4

Citations

890

H-Index

4

Active since

2016

Affiliations

Vall d'Hebron Hospital Universitari(Current)

Cancer Genomics Centre

Cancer Research UK Cambridge Center

Universitat Autònoma de Barcelona

Vall d'Hebron Institute of Oncology

Marta Castroviejo‐Bermejo is an author at Vall d'Hebron Hospital Universitari specializing in cancer therapeutics, pathology, and tumor biology.

ORCID

Top concepts

Publications per year

2016–2022

4

Publications

4

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

Cristina Cruz, Marta Castroviejo‐Bermejo, Sara Gutiérrez‐Enríquez et al. · Annals of Oncology · 2018 · 410 citations · Full text

A <scp>RAD</scp> 51 assay feasible in routine tumor samples calls <scp>PARP</scp> inhibitor response beyond <scp>BRCA</scp> mutation

Marta Castroviejo‐Bermejo, Cristina Cruz, Alba Llop‐Guevara et al. · EMBO Molecular Medicine · 2018 · 263 citations · Full text

BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1

Rinske Drost, Kiranjit K. Dhillon, Hanneke van der Gulden et al. · Journal of Clinical Investigation · 2016 · 137 citations · Full text

, , +18

Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance

Violeta Serra, Anderson T. Wang, Marta Castroviejo‐Bermejo et al. · Clinical Cancer Research · 2022 · 80 citations · Full text

1–4 of 4